At the 2026 Digestive Disease Week in the United States, Yangtze River Pharmaceutical Group achieved a significant milestone when its product, Biling Weitong Granules, was included in the internationally authoritative Rome V Clinical Criteria and Guidelines.

The 34th East China Import and Export Fair concluded on March 4 after four days of exhibitions and business exchanges, with companies from Taizhou, Jiangsu, achieving strong results.

Overseas Pharmaceuticals has entered strategic partnerships with two major multinational drugmakers in Europe and South America to develop controlled-release medicines for global markets.

Jiangsu Xingyang Marine Equipment Manufacturing, located in the Jiangyan Economic Development Zone, Taizhou, has secured orders through 2028, underscoring its strong market position.

Located in the Taixing Economic Development Zone, GEM (Jiangsu) Cobalt has built a thriving business centered on green smelting, high-end material manufacturing and resource recycling.

The construction of the Haoxianglai Leisure Food Industrial Park commenced in Xinghua, Jiangsu province, on Nov 26.

Shuangdeng Group's energy storage business for artificial intelligence data centers continued its strong growth in the first half of the year.

Xiuzheng Pharmaceutical, one of China's top 10 pharmaceutical companies, commenced construction on its East China R&D and Manufacturing Center in Jiangyan on Oct 28.